Catalyst Biosciences, Inc. (CBIO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.7800 |
| Open | 1.7500 |
| Bid | 1.7600 x 3200 |
| Ask | 1.8100 x 1100 |
| Day's Range | 1.7500 - 1.8398 |
| 52 Week Range | 0.3500 - 5.2000 |
| Volume | |
| Avg. Volume | 6,620,921 |
| Market Cap | 56.223M |
| Beta (5Y Monthly) | 1.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.0550 |
| Earnings Date | Mar 02, 2022 - Mar 07, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Aug 20, 2015 |
| 1y Target Est | 11.33 |
- GlobeNewswire
Catalyst Biosciences Announces Plan to Distribute Cash to Stockholders
Board is Committed to Maximizing the Amount of Cash the Company Distributes to Stockholders Decision Follows Recent Sale of Certain Assets and Extensive Engagement with Stockholders Board Will Set Initial Distribution Date and Amount Once Potential Liability and Expenses Associated with Stockholder Litigation and Proxy Contest Are Known SOUTH SAN FRANCISCO, Calif., June 29, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) (the “Company” or “we”) today announced its intention to
- Zacks
Has Catalyst Biosciences (CBIO) Outpaced Other Medical Stocks This Year?
Here is how Catalyst Biosciences, Inc. (CBIO) and Humana (HUM) have performed compared to their sector so far this year.
- American City Business Journals
The Petri Dish: NIH gives $68M to Pfizer-partnered AI startup
A roindup of companies developing drugs and devices, inking new partnership deals, raising money, expanding facilities and more.
